AngioDynamics Azione

AngioDynamics Debiti verso fornitori

Il Debiti Commerciali di AngioDynamics (ANGO) al 8 ago 2026 è 31,51 Mio. USD. L'anno precedente, Debiti Commerciali era 33,29 Mio. USD — una variazione del -5,34% (inferiore).

Debiti verso fornitori

31,51 Mio.USD

YoY

-5,34%

Ultimo aggiornamento:

Debiti Commerciali di AngioDynamics ammonta a 2026 31,51 Mio. USD. Debiti Commerciali di AngioDynamics ammontava a 2025 33,29 Mio. USD. Diminuisce del -5,34% inferiore rispetto all'anno precedente.
Access this data via the Eulerpool API

AngioDynamics Analisi delle Azioni

Cosa fa AngioDynamics? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su AngioDynamics azioni

Debiti Commerciali di AngioDynamics è 31,51 Mio. USD nel 2026.

Il Debiti Commerciali di AngioDynamics è passato da 33,29 Mio. USD a 31,51 Mio. USD, con una variazione del -5,34 %. Il valore è inferiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del AngioDynamics di Debiti Commerciali dal 2006, con valori annuali, grafici e analisi dettagliate.

I debiti commerciali rappresentano il denaro dovuto ai fornitori per beni e servizi ricevuti. È un componente fondamentale della gestione del capitale di esercizio.

Il USD di Debiti Commerciali è un fattore chiave per gli investitori. I cambiamenti in questa metrica possono segnalare il miglioramento o il deterioramento dei fondamentali, impattando direttamente il prezzo delle azioni. Su Eulerpool puoi tracciare il AngioDynamics di Debiti Commerciali storicamente e in tempo reale.

Access this data via the Eulerpool API

Bilancio — AngioDynamics

Tutte le Metriche Finanziarie — AngioDynamics